Insights

Insights From Our Experts

Articles

BLOG: Population Health Leadership

“Population health” is the result of pushing health systems to be clinically and financially responsible for their communities. This is a significant shift from simply being focused on the volume of services delivered within the hospital.  The focus on population health represents a movement for pharma from…

Leveraging RWE to Enhance Experiences Across the Patient Journey

In a tech-driven healthcare ecosystem in which patients are engaged consumers, product value is contingent on treatment outcomes and patient success. With digital tools and resources at their fingertips, today’s patient is empowered to make informed…

Reinventing Launch: The Gold Standard Of Drug Commercialization

In a world that is rapidly changing, we must evolve beyond traditional strategies to create true impact for patients. EVERSANA's complete end-to-end commercialization model enables manufacturers to bring their drug to market at a fraction of…

The Crush: How Covid-19 Is Impacting Mature Brand Revenue & Long-Term Value

The impact of COVID is reverberating across all aspects of society and business. In the healthcare industry, hundreds of thousands of patients are not getting proper access to and utilization of therapies that can improve their…

Reimbursement May Be on the Way for Remote Therapeutic Monitoring

The American Medical Association (AMA) manages the procedure code set that physicians and other healthcare professionals use to identify the services for which they bill. These codes are commonly known as the CPT® code set, which…

BLOG: “Payvider” Growth Continues — But Not From the Payers

“Payviders” is the term used to describe the coming together of both payers and providers. In the past several years this has been driven primarily by provider consolidation. As these providers have grown into large, sophisticated groups or wind up under health systems, they seek out risk — serving…

How to Determine Price and Global Launch Sequence in a Post-COVID World

“Just because you’ve launched, it doesn’t mean you can relax. You always need to have your ear to the ground globally as to what’s going on.” —Ed Corbett, Head of EMEA, EVERSANA™ MANAGEMENT CONSULTING The globe…

Supporting Successful Commercialization With Integrated Compliance

Compliance is an integral part of the entire biopharma, medical device and product lifecycle, yet it poses one of the biggest challenges for our customers. While they try to focus on driving value, innovation and patient…

Transforming Pharma With Industry-Leading Partnerships

EVERSANA is filling an influx of essential commercialization needs to overcome strained resources and support COVID-19 treatment launches. From groundbreaking treatments to long-overdue therapy improvements, there will be at least five new treatments headed to market…

Alternative Product Distribution Model: Where Agility Meets Profitability

The power of medicine is affecting current events more than ever as global well-being hinges on COVID-19 vaccines. As investments and research are poured into medical innovation, pharmaceutical manufacturers must decide how to get life-saving products…